Pertactin-negative Variants of Bordetella pertussis in the United States

New England Journal of Medicine

Volumn 368, Issue 6, 2013, Pages 583-584

  Queenan, Anne Marie ^a   Cassiday, Pamela K ^b   Evangelista, Alan ^c  

^a JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PERTACTIN;

BACTERIAL GENE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BORDETELLA PERTUSSIS; GENE AMPLIFICATION; GENE INSERTION SEQUENCE; GENE MUTATION; GENE SEQUENCE; LETTER; NONHUMAN; PRIORITY JOURNAL; PRN2 GENE; STOP CODON; UNITED STATES;

EID: 84873494311     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1209369     Document Type: Letter

References (5)

1. Klein NP, Bartlett J, Rowhani-Rahbar A, Firemean B, Baxter R. Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med 2012;367:1012-9.
2. Hegerle N, Paris A-S, Brun D, et al. Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin. Clin Microbiol Infect 2012;18(9):E40-E46.
3. Barkoff A-M, Mertsola J, Guillot S, Guiso N, Berbers G, He Q. Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland. Clin Vaccine Immunol 2012;19:1703-4.
4. Mooi FR, Hallander H, Wirsing von König CH, Hoet B, Guiso N. Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur J Clin Microbiol Infect Dis 2000;19:174-81.
5. Schmidtke AJ, Boney KO, Martin SW, Skoff TH, Tondella ML, Tatti KM. Population diversity among Bordetella pertussis isolates, United States, 1935-2009. Emerg Infect Dis 2012;18:1248-55.